Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress
R Magierski, T Sobow, E Schwertner… - Frontiers in …, 2020 - frontiersin.org
The core symptoms of different dementia subtypes are the behavioral and psychological
symptoms of dementia (BPSD) and its neuropsychiatric symptoms (NPS). BPSD symptoms …
symptoms of dementia (BPSD) and its neuropsychiatric symptoms (NPS). BPSD symptoms …
The interRAI suite of mental health assessment instruments: an integrated system for the continuum of care
The lives of persons living with mental illness are affected by psychological, biological,
social, economic, and environmental factors over the life course. It is therefore unlikely that …
social, economic, and environmental factors over the life course. It is therefore unlikely that …
Terminology and assessment tools of psychosis: A systematic narrative review
N Seiler, T Nguyen, A Yung… - Psychiatry and clinical …, 2020 - Wiley Online Library
Aim Phenomena within the psychosis continuum that varies in frequency/duration/intensity
have been increasingly identified. Different terms describe these phenomena, however …
have been increasingly identified. Different terms describe these phenomena, however …
Bipolar disorder and manic-like symptoms in Alzheimer's, vascular and frontotemporal dementia: A systematic review
Background: An increased risk of manic episodes has been reported in patients with
neurodegenerative disorders, but the clinical features of bipolar disorder (BD) in different …
neurodegenerative disorders, but the clinical features of bipolar disorder (BD) in different …
Inter-provincial variation in older home care clients and their pathways: a population-based retrospective cohort study in Canada
L Mitchell, J Poss, M MacDonald, R Burke, JM Keefe - BMC geriatrics, 2023 - Springer
Abstract Background In Canada, publicly-funded home care programs enable older adults to
remain and be cared for in their home for as long as possible but they often differ in types of …
remain and be cared for in their home for as long as possible but they often differ in types of …
Risks and benefits of current and novel drugs to treat agitation in Alzheimer's disease
Introduction At present, no pharmacological interventions have been approved for the
treatment of agitation in Alzheimer's disease (AD), an important neuropsychiatric symptom …
treatment of agitation in Alzheimer's disease (AD), an important neuropsychiatric symptom …
Long-term care resident health and quality of care during the COVID-19 pandemic: a synthesis analysis of Canadian Institute for Health Information data tables
Objective: Long-term care (LTC) homes (“nursing homes”) were challenged during the first
year of the COVID-19 pandemic in Canada. The objective of this study was to measure the …
year of the COVID-19 pandemic in Canada. The objective of this study was to measure the …
Optimizing Practices, Use, Care and Services–Antipsychotics (OPUS-AP) in long-term care centers in Québec, Canada: A strategy for best practices
B Cossette, MA Bruneau, Y Couturier, S Gilbert… - Journal of the American …, 2020 - Elsevier
Objectives Antipsychotic medications are often used for the first-line management of
behavioral and psychological symptoms of dementia (BPSD) contrary to guideline …
behavioral and psychological symptoms of dementia (BPSD) contrary to guideline …
Exploring acute care nurses' decision‐making in psychotropic PRN use in hospitalised people with dementia
Aims and objectives To understand how acute care nurses make decisions about
administering “as‐needed”(PRN) psychotropic medications to hospitalised people with …
administering “as‐needed”(PRN) psychotropic medications to hospitalised people with …
Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study
Objective To develop information leaflets for older inpatients and/or their carers to support
deprescribing of antipsychotics, benzodiazepines/Z-drugs and proton pump inhibitors …
deprescribing of antipsychotics, benzodiazepines/Z-drugs and proton pump inhibitors …